Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease

American Journal of Pathology

Volumn 151, Issue 5, 1997, Pages 1455-1467

  Simpson, Karen L ^a   Jones, Anita ^a   Norman, Susan ^a   Holmes, Christopher H ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR;

ARTICLE; CANCER INVASION; CELL COMPARTMENTALIZATION; COMPLEMENT ACTIVATION; EFFECTOR CELL; ENZYME REGULATION; HUMAN; HUMAN TISSUE; MEMBRANE BINDING; PRECANCER; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SQUAMOUS EPITHELIUM; UTERINE CERVIX CANCER;

ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; EPITHELIUM; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; PRECANCEROUS CONDITIONS; PREGNANCY; REFERENCE VALUES; UTERINE CERVICAL NEOPLASMS;

EID: 0030726536     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Kinoshita T: Biology of complement: the overture. Immunol Today 1991, 12:291-295
2. Atkinson JP, Farries T: Separation of self from non self in the complement system. Immunol Today 1987, 8:212-215
3. Lublin DM, Atkinson JP: Decay-accelerating factor: biochemistry, molecular biology and function. Annu Rev Immunol 1989, 7:35-58
4. Seya T, Atkinson JP: Functional properties of membrane cofactor protein of complement. Biochem J 1989, 264:581-588
5. Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ: Human protectin (CD59), an 18-20000 MW complement lysis restricting factor, inhibits C5b-9 catalysed insertion of C9 into lipid bilayers. Immunology 1990, 71:1-9
6. Rollins SA, Zhoa J, Ninomiya H, Sims PJ: Inhibition of homologous complement by CD59 is mediated by a species selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J Immunol 1991, 146:2345-2351
7. McNearney T, Ballard L, Seya T, Atkinson JP: Membrane cofactor protein of complement is present on human fibroblast, epithelial and endothelial cells. J Clin Invest 1989, 84:538-545
8. Nose M, Katoh M, Okada N, Kyogoku M, Okada H: Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression in endothelial cells in vivo. Immunology 1990, 70:145-149
9. Meri S, Waldmann H, Lachmann PJ: Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 1991, 65:532-537
10. Sayama K, Shiraishi S, Miki Y: Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages and in benign and malignant skin neoplasms. Br J Dermatol 1992, 127:1-4
11. Yamakawa M, Yamada K, Tsuge T, Ohrui H, Ogata T, Dobashi M, Imai Y: Protection of thyroid cancer cells by complement-regulatory factors. Cancer 1994, 73:2808-2817
12. Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP: Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol 1996, 149:129-142
13. Bjorge L, Hakulinen J, Wahlstrom T, Matre R, Meri S: Complement regulatory proteins in ovarian malignancies. Int J Cancer 1997, 70: 14-25
14. Kumar S, Vinci JM, Pytel BA, Baglioni C: Expression of messenger RNAs for complement inhibitors in human tissues and tumors. Cancer Res 1993, 53:348-353
15. Shinoura N, Heffelfinger SC, Miller M, Shamraj OI, Miura N-H, Larson JL, DeTribolet N, Warnick RE, Tew JJ, Menon AG: RNA expression of complement regulatory proteins in human brain tumors. Cancer Lett. 1994, 86:143-149
16. Cheung N-KV, Walter EI, Smith-Mensah WH, Ratnoff WD, Tykocinski ML, Medof ME: Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. J Clin Invest 1988, 81:1122-1128
17. Seya T, Hara T, Matsumoto M, Akedo H: Quantitative analysis of membrane cofactor protein (MCP) of complement: high expression of MCP on human leukemia cell lines, which is down regulated during cell differentiation. J Immunol 1990, 145:238-245
18. Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V: Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 1987, 165:848-864
19. Oglesby TJ, Longwith JE, Huettner PC: Human complement regulator expression by the normal female reproductive tract. Anat Rec 1996, 246:78-86
20. Holmes CH, Simpson KL, Wainwright SD, Tate CG, Houlihan JM, Sawyer IH, Rogers IP, Spring FA, Anstee DJ, Tanner MJ: Preferential expression of the complement regulatory protein decay accelerating factor at the feto-maternal interface during human pregnancy. J Immunol 1990, 144:3099-3105
21. Fletcher A, Bryant JA, Gardner B, Judson PA, Spring FA, Parsons SF, Mallinson G, Anstee DJ: New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria patients and for the quantitation of CD59 on normal and decay-accelerating factor (DAF)-deficient erythrocytes. Immunology 1992, 75:507-512
22. Sparrow RL, McKenzie IFC: HuLy-m5: a unique antigen physically associated with HLA molecules. Hum Immunol 1983, 7:1-15
23. Pesando JM, Stucki M, Hoffman P: Altered expression of surface antigens with the appearance of class II molecules on a malignant human B cell line. Hum Immunol 1987, 19:235-243
24. Sunderland CA, Davies JO, Stirrat GM: Immunohistology of normal and ovarian cancer tissue with a monoclonal antibody to placental alkaline phosphatase. Cancer Res 1984, 44:4496-4502
25. Simpson KL, Houlihan JM, Holmes CH: Complement regulatory proteins in early fetal life: CD59, membrane cofactor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver. Immunology 1993, 80:183-190
26. Simpson KL, Holmes CH: Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis. Immunology 1994, 81:452-461
27. Smith NC, Brush MG, Luckett S: Preparation of placental villous surface membrane. Nature 1974, 252:302-303
28. Towbin H, Staehlin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354
29. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-681
30. Holmes CH, Simpson KL, Okada H, Okada N, Wainwright SD, Purcell DFJ, Houlihan JM: Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 1992, 22:1579-1585
31. Russell SM, Sparrow RL, McKenzie IFC, Purcell DFJ: Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol 1992, 22:1513-1518
32. Bora NS, Post TW, Atkinson JP: Membrane cofactor protein of the complement system: a HindIII restriction length polymorphism that correlates with the expression polymorphism. J Immunol 1991, 146: 2821-2825
33. Cervoni F, Oglesby TJ, Fenichel P, Dohr G, Rossi B, Atkinson JP, Hsi B-L: Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa. J Immunol 1993, 151:939-948
34. Skeie Jensen T, Bjorge L, Wollen A-L, Ulstein M: Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion. Am J Reprod Immunol 1995, 34:1-9
35. Sayama K, Shiraishi S, Shirakata Y, Kobayashi Y, Miki Y: Characterisation of decay-accelerating factor (DAF) in human skin. J Invest Dermatol 1991, 96:61-64
36. Liszewski MK, Tedja I, Atkinson JP: Membrane cofactor protein (CD46) of complement: processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem 1994, 269:10776-10779
37. Bryant RW, Granzow CA, Siegel MI, Egan RW, Billah MM: Phorbol esters increase synthesis of decay-accelerating factor, a phosphatidylinositol-anchored surface protein, in human endothelial cells. J Immunol 1991, 147:1856-1862
38. Bryant RW, Granzow CA, Siegel MI, Egan RW, Billah MM: Wheat germ L-agglutinin and other selected lectins increase synthesis of decay-accelerating factor in human endothelial cells. J Immunol 1991, 147:1856-1862
39. Tsuji S, Kaji K, Nagasawa S: Decay-accelerating factor on human umbilical endothelial cells: its histamine-induced expression and spontaneous shedding from the cell surface. J Immunol 1993, 152: 1404-1410
40. Shibata T, Cosio FG, Birmingham DJ: Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol 1991, 147:3901-3908
41. Cui W, Atkinson JP: The regulation of expression of membrane co-factor protein MCP;CD46. FASEB J 1994, 8:A765
42. Bjorge L, Skeie Jensen T, Ulvestad E, Vedeler CA, Matre R: The influence of tumour necrosis factor-α, interleukin-1β and interferon-γ on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29. Scand J Immunol 1995, 41:350-356
43. Bjorge L, Skeie Jensen T, Matre R: Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line. Cancer Immunol Immunother 1996, 42:185-192
44. Price RJ, Boettcher B: The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement dependent immobilising antibodies. Fertil Steril 1979, 32:61-66
45. Davis LS, Patel SS, Atkinson JP, Lipsky PE: Decay accelerating factor functions as a signal transducing molecule for human T cells. J Immunol 1988, 141:2246-2252
46. Korty PE, Brando C, Shevach EM: CD59 functions as a signal transducing molecule for human T cell activation. J Immunol 1991, 146: 4092-4098
47. Cinek T, Horesji V: The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J Immunol 1992, 149:2262-2270
48. Nowicki B, Hart A, Coyne KE, Lublin DM, Nowicki S: Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognised by Escherichia coli recombinant Dr adhesin in a model of cell-cell interaction. J Exp Med 1993, 178:2115-2121
49. Okada N, Liszewski MK, Atkinson JP, Caparon M: Membrane cofactor protein (MCP, CD46) is a keratinocyte receptor for the M protein of group A streptococcus. Proc Natl Acad Sci USA 1995, 92:2489-2493
50. Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW: Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echo-viruses. Proc Natl Acad Sci USA 1994, 91:6245-6248
51. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D: Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993, 67:6025-6032
52. Dorig RE, Marcil A, Chopra A, Richardson CD: The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993, 75:295-305